These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


144 related items for PubMed ID: 4743271

  • 1. [Correlation of biochemical findings and the state of the neuromuscular apparatus in patients with parkinsonism during use of decimeter wave therapy].
    Strelkova NI, Zeĭnalov RK.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(2):216-20. PubMed ID: 4743271
    [No Abstract] [Full Text] [Related]

  • 2. [Catecholamine excretion and treatment of parkinsonism with midantan].
    Kandel' EI, Iadgarov IS.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1976 Sep; 76(9):1323-6. PubMed ID: 1015136
    [No Abstract] [Full Text] [Related]

  • 3. [The role of heredity in Parkinson's disease].
    Atadzhanov M.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973 Sep; 73(2):195-9. PubMed ID: 4743268
    [No Abstract] [Full Text] [Related]

  • 4. [The reserpine model of parkinsonism and changes in the metabolism of mediators].
    Tret'iakova KA, Samoĭlova ZT.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973 Sep; 73(2):220-4. PubMed ID: 4743272
    [No Abstract] [Full Text] [Related]

  • 5. [Disputable problems with regard to the main forms of parkinsonism].
    Levin GZ.
    Klin Med (Mosk); 1977 Sep; 55(9):84-9. PubMed ID: 926744
    [No Abstract] [Full Text] [Related]

  • 6. Amantadine hydrochloride in treatment of Parkinsonism.
    Nagaswami S, Nagaswami R.
    Dis Nerv Syst; 1973 Sep; 34(5):253-8. PubMed ID: 4782280
    [No Abstract] [Full Text] [Related]

  • 7. [Quantitative testing methods for objectification of the effect of prolonged L-dopa therapy in parkinsonism].
    Gerstenbrand F, Grünberger J, Schubert H.
    Nervenarzt; 1973 Aug; 44(8):428-33. PubMed ID: 4733895
    [No Abstract] [Full Text] [Related]

  • 8. [Certain features of the clinical picture and pathomorphology of Parkinson disease of different etiology].
    Martynov IuS, Zenkevich GS, Tochilovskiĭ AS.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980 Aug; 80(7):1033-9. PubMed ID: 7415721
    [Abstract] [Full Text] [Related]

  • 9. [Therapy and problems of parkinsonism].
    Albert E.
    Nervenarzt; 1971 May; 42(5):225-41. PubMed ID: 4942900
    [No Abstract] [Full Text] [Related]

  • 10. [Trans-cerebral electrophoresis of L-DOPA in the complex treatment of parkinsonism].
    Neĭmark EZ, Evtushenko SK, Dukhovnaia MA.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984 May; 84(9):1334-8. PubMed ID: 6506979
    [Abstract] [Full Text] [Related]

  • 11. [The effect of alpha-DOPA on the dynamics of urinary excretion of DOPA, catecholamines and their metabolites in healthy subjects and in patients with parkinsonism].
    Matlina ESh, Kandel' EI, Vasil'ev VN, Iadgarov IS, Bol'shakova TD.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973 May; 73(2):205-9. PubMed ID: 4743269
    [No Abstract] [Full Text] [Related]

  • 12. [Pathogenesis and treatment of manganese induced Parkinsonism].
    Ryzhkova MN, Tarasova LA.
    Gig Tr Prof Zabol; 1975 Nov; (11):31-4. PubMed ID: 1205189
    [No Abstract] [Full Text] [Related]

  • 13. [Combined treatment of Parkinsonism with levopa, midantan and anticholinergic drugs].
    Evtushenko SK.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1976 Dec; 76(12):1797-1802. PubMed ID: 1015115
    [Abstract] [Full Text] [Related]

  • 14. [Results of treatment of Parkinsonism with L-dopa].
    De Divitiis E, D'Andrea F, Signorelli CD.
    Sist Nerv; 1970 Dec; 22(2):99-108. PubMed ID: 5504563
    [No Abstract] [Full Text] [Related]

  • 15. [L-dopa treatment of persons with parkinsonism in a hospital for geriatric rehabilitation].
    Antonini F, Baroni A, Roveyaz L.
    Sist Nerv; 1970 Dec; 22(2):74-81. PubMed ID: 5504560
    [No Abstract] [Full Text] [Related]

  • 16. [Decimeter wave therapy in the rehabilitation of stroke patients].
    Sitel' AB.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981 Dec; 81(8):1166-72. PubMed ID: 7315052
    [Abstract] [Full Text] [Related]

  • 17. [Biochemical evaluation of the effectiveness of antiparkinson preparations containing L-DOPA].
    Vartanian KZ.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981 Dec; 81(12):1777-81. PubMed ID: 6803476
    [Abstract] [Full Text] [Related]

  • 18. [The excretion of adrenaline, noradrenaline and their precursors (DOPA and dopamine) in migraine patients].
    Gol'dman NB, Matlina ESh, Fets AN.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1970 Dec; 70(2):199-203. PubMed ID: 5439831
    [No Abstract] [Full Text] [Related]

  • 19. [Effect of decimetric waves on the functional state of the neuromuscular apparatus in rheumatoid arthritis].
    Vasil'eva GS.
    Vopr Kurortol Fizioter Lech Fiz Kult; 1974 Dec; (4):356-9. PubMed ID: 4462287
    [No Abstract] [Full Text] [Related]

  • 20. [Changes of catecholamine metabolism and symptoms of parkinsonism in rats with manganotoxicosis].
    Samoĭlova ZT, Shavolina VA.
    Gig Tr Prof Zabol; 1974 Apr; 18(4):16-20. PubMed ID: 4845000
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.